ANTITUMOR-VEKTORKONSTRUKTE UND METHODEN

European patent · EP0870018 · Deleted

Register entry

Publication number
EP0870018
Application number
EP96932702
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 2, 1996
Published
Oct 14, 1998
Granted
Mar 27, 2002
Deleted
Oct 31, 2006
Reason
Annual fee unpaid
IPC classes
C12N 15/12 (2006.01)
C12N 15/54 (2006.01)
C12N 15/62 (2006.01)
C12N 15/63 (2006.01)
C12N 15/85 (2006.01)
C12N 5/10 (2006.01)
C07K 14/245 (2006.01)
C07K 14/435 (2006.01)
C07K 14/47 (2006.01)
C07K 14/82 (2006.01)
C12Q 1/68 (2006.01)
Priority
GB 9520079 02.10.1995
GB 9616685 08.08.1996
PCT application
PCT/GB1996/002416 02.10.1996
PCT publication
WO1997/012970 10.04.1997
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 15, 2007

    Deleted, fee unpaid

    Published in +pat+ No 11 in 2007

  2. Mar 28, 2002

    Granted

    Published in PIDTJ No 6 in 2002

Parties

Holder

Cyclacel Limited

Marquis House, 67-68 Jermyn Street, London SW1Y 6NY, GB

Inventor

BALMAIN, Allan;c/o Onyx Pharmaceuticals

Richmond, CA 94806, US

ZHU, Jingde

Glasgow G61 1LN, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.